WIINBERG ULF bought INKT
March 2, 2026 · Form 4 insider transaction
WIINBERG ULF bought 1,285 shares of MiNK Therapeutics, Inc. at $10.90 per share, a transaction worth $14.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 92 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,285
Price
$10.90
Total value
$14.0K
InsiderWIINBERG ULF
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 2, 2026
Filing dateJune 2, 2026
Shares owned after21,519
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Due to an administrative error, the RSUs for Q1 2026 Board and committee compensation were not filed timely.